Synalar
NDC Package 43538-920-99
Package Information
Synalar is a medication used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash). Marketed by Medimetriks Pharmaceuticals, Inc., this product is identified by NDC 43538-920 and is authorized under FDA application NDA015296.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 43538 - Medimetriks Pharmaceuticals, Inc.
- 43538-920 - Synalar
- 43538-920-99 - 1 BOTTLE, WITH APPLICATOR in 1 CARTON / 13 mL in 1 BOTTLE, WITH APPLICATOR
- 43538-920 - Synalar
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (43538-920). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 43538-920-99 identifies a specific commercial package of 1 bottle, with applicator in 1 carton / 13 ml in 1 bottle, with applicator of Synalar, labeled by Medimetriks Pharmaceuticals, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Medimetriks Pharmaceuticals, Inc. on May 31, 2012. The current certification is valid through October 01, 2023.
What are the primary indications for this medication?
This medication is used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash). Fluocinolone reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a medium-strength corticosteroid.
How is this Medimetriks Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 43538092099. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.